This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
It’s still up to the FDA to decide whether to greenlight the substances for compounding pharmacies to make—and pave the way for a peptide gold rush https://www.wsj.com/health/healthcare/fda-committee-votes-in-favor-of-several-popular-and-controversial-peptides-2237282b?mod=rssfeed
2026-07-24T18:29:15.675Z